Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8648069 5-substituted indazoles as kinase inhibitors

Patent 8648069 was granted and assigned to AbbVie Inc. on February, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

AbbVie Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

86480690

Patent Inventor Names

Irini Akritopoulou-Zanze0

Julie M. Miyashiro0

Jyoti R. Patel0

Kathy A. Sarris0

Keith W. Woods0

Lu Wang0

Margaretha Bakker0

Melissa J. Michmerhuizen0

...

Date of Patent

February 11, 2014

Patent Application Number

123279910

Date Filed

December 4, 2008

Patent Citations Received

‌

US Patent 11713315 5 to 7 membered heterocyclic amides as JAK inhibitors

‌

US Patent 11786517 Methods of treatment using a JAK inhibitor compound

‌

US Patent 12122773 Crystalline hydrate of a JAK inhibitor compound

‌

US Patent 11912719 Substituted isoquinolines as rock kinase inhibitors

‌

US Patent 11878977 JAK inhibitors containing a 4-membered heterocyclic amide

‌

US Patent 11702415 Crystalline hydrate of a JAK inhibitor compound

Patent Primary Examiner

‌

Alicia L Otton

Patent abstract

The present invention relates to compounds of formula (I) or pharmaceutical acceptable salts,

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8648069 5-substituted indazoles as kinase inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API